Myriad Genetics
MYGN
MYGN
234 hedge funds and large institutions have $3.13B invested in Myriad Genetics in 2015 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 70 increasing their positions, 95 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
35% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 40
Holders
234
Holding in Top 10
2
Calls
$18.1M
Puts
$21.9M
Top Buyers
| 1 | +$37.8M | |
| 2 | +$33.8M | |
| 3 | +$23M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$16.8M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$15.2M |
Top Sellers
| 1 | -$21.7M | |
| 2 | -$19.7M | |
| 3 | -$17M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$16.2M |
| 5 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$15.6M |